4//SEC Filing
Thompson Alexis A. 4
Accession 0000899243-21-012738
CIK 0001629137other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:10 PM ET
Size
8.2 KB
Accession
0000899243-21-012738
Insider Transaction Report
Form 4
Thompson Alexis A.
Director
Transactions
- Award
Restricted Stock Units
2021-03-17+7,200→ 7,200 total→ Common Stock (7,200 underlying) - Award
Stock Option (Right to Buy)
2021-03-17+11,200→ 11,200 totalExercise: $44.28Exp: 2031-03-16→ Common Stock (11,200 underlying)
Footnotes (2)
- [F1]The shares of Common Stock underlying the option vest in 36 equal monthly installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. This option is subject to accelerated vesting upon a change of control of the Issuer.
- [F2]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001851895
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:10 PM ET
- Size
- 8.2 KB